Skip to main content
S&P 5007,591.70-0.58%DOW52,064.10-0.60%NASDAQ26,081.72-0.65%BTC$76,799.00-1.71%ETH$2,453.65-0.48%GOLD$4,367.20-0.91%OIL$103.26+0.76%
Smart Investors Daily
CA

OTC · CAWW

CCA Industries, Inc.

Consumer Defensive · Household & Personal Products

$0.45

Up+$0.00 (+0.00%)

Updated Sep 11, 2026, 3:31 AM

SID Score

3.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
4.99M
P/E ratio
-0.86
Dividend yield
0.00%
52-week range
$0.20 – $0.93
Volume
18.9K
Avg. volume
3.64K

Price performance

CAWW price history

1M range · 2 trading sessions · Daily adjusted prices

CAWW closed at $0.45 after 2 trading sessions, up 0.00% for the selected period.

Last close
$0.45
Period change
+0.00%
Period low
$0.45
Period high
$0.45
Daily close
View OHLC price history
CAWW OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 4, 2026$0.45$0.525$0.43$0.4518.9K
Aug 17, 2026$0.45$0.45$0.45$0.451K

Latest CAWW news

The latest Smart Investors Daily articles mentioning CAWW.

Stock researchCompany · Overview

CAWW research

Overview

Company profile and research snapshot.

Company profile

CCA INDUS INC

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Feb 5, 2026

Kingsway Pharmaceuticals Welcomes Lobe Miracle® to Its Family of Trusted Brands

Kingsway Pharmaceuticals, LLC announced today that it has officially acquired the Lobe Miracle® brand from CCA Industries, Inc., marking a significant step in the company's continued expansion within the consumer healthcare space. This purchase strengthens Kingsway's portfolio of trusted, practical solutions designed to support everyday wellness needs. Lobe Miracle®, a longstanding and well‑regarded product created to improve earlobe comfort and appearance, will transition under Kingsway's owner

Yahoo · Feb 4, 2026

CCA Industries, Inc. Announces Sale of Lobe Miracle Brand

FORT WASHINGTON, PA / ACCESS Newswire / February 4, 2026 / CCA Industries, Inc. (OTCID:CAWW) has sold its Lobe Miracle brand to Kingsway Pharmaceuticals, LLC effective January 29, 2026. The brand was sold for $1,200,000 plus inventory at cost for ...

Benzinga · Apr 15, 2025

CCA Industries, Inc. Reports Results of Operations for the Quarter ended February 28, 2025

CCA Industries reported a net income of $13,731 for the first quarter of fiscal 2025, compared to a loss of $245,410 in the same period of 2024. The company's EBITDA also improved significantly, from a loss of $288,499 in Q1 2024 to a positive $40,209 in Q1 2025. The CEO attributed the turnaround to strategic decisions to cut unprofitable sales and focus on bottom-line gains.

Benzinga · Feb 28, 2025

CCA Industries, Inc. Reports Financial Results for Year Ended November 30, 2024

CCA Industries reported a net loss of $6.1 million for the year ended November 30, 2024, compared to a net loss of $422,866 in the previous year. The company made significant restructuring changes, including consolidating warehouses, which lowered operating costs. However, the company also had non-cash adjustments, including a write-down of its deferred tax asset, resulting in an additional tax expense of $4.6 million.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By